Medpace Holdings, Inc.
MEDP Healthcare Diagnostics & Research
Medpace Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.5 billion, up 20.0% from fiscal 2024.
- Revenue
- +8.50%
- EPS
- +24.6%
- Free cash flow
- −16.6%
Quarter to September 2026, against a year earlier
Follow MEDP
Alert me
Medpace Holdings, Inc. (MEDP) Current ratio
Medpace Holdings, Inc.'s current ratio at the end of the quarter to 30 September 2026 was 0.8×, up 0.1× from fiscal 2025 (0.7×). Over the past ten years it has ranged from 0.4× (fiscal 2022) to 1.2× (fiscal 2021); the current reading is higher than 55% of that period. That is below the Diagnostics & Research industry median of 2.3× and below the Healthcare sector median of 3.1×.
Current ratio, annual
Embed this chart
Annual newest first
| Period | Current ratio | Change |
|---|---|---|
| FY2025 | 0.7× | (20.96%) |
| FY2024 | 0.9× | 45.16% |
| FY2023 | 0.6× | 54.45% |
| FY2022 | 0.4× | (66.48%) |
| FY2021 | 1.2× | 15.21% |
| FY2020 | 1.1× | 16.43% |
| FY2019 | 0.9× | 33.38% |
| FY2018 | 0.7× | 2.74% |
| FY2017 | 0.7× | (14.65%) |
| FY2016 | 0.8× | 11.81% |
Quarterly newest first
| Period | Current ratio | Change |
|---|---|---|
| Sep 2026 | 0.8× | 13.74% |
| Jun 2026 | 0.7× | (13.60%) |
| Mar 2026 | 0.8× | 14.99% |
| Dec 2025 | 0.7× | 28.27% |
| 37 more quarters | Free account |
Against its own ten years
Current ratio against peers
| Company | Current ratio |
|---|---|
| GH Guardant Health, Inc. compare | 3.6× |
| QGEN QIAGEN N.V. compare | 2.8× |
| RVTY Revvity Inc. compare | 2.7× |
| ILMN Illumina, Inc. compare | 2.6× |
| DGX Quest Diagnostics Incorporated compare | 1.7× |
| CRL Charles River Laboratories International, Inc. compare | 1.4× |
| LH Labcorp Holdings Inc. compare | 1.4× |
| ICLR ICON PLC compare | 1.3× |
| MEDP Medpace Holdings, Inc. | 0.8× |
| Diagnostics & Research industry median | 2.3× |
| Healthcare sector median | 3.1× |
| Market median | 1.6× |
What Current ratio is
Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.
Current Assets (Total) ÷ Current Liabilities (Total)
More on MEDP
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement